Literature DB >> 11376558

Strain-dependency of chromosomal abnormalities in lymphomas developed in E mu-myc transgenic mice.

K Akagi1, K Yamamura.   

Abstract

We previously showed that B and T cell lymphoma development in Em (immunoglobulin heavy chain enhancer)-myc transgenic mice is dependent on the mouse strain. To determine whether any non-random chromosomal abnormality that was present was caused by variations in the lymphoma cell type or by a different genetic background, we crossed C3H transgenic mice with other inbred strains of mice, C57BL / 6 or BALB / c. Cytogenetic analysis showed a high frequency of non-random chromosomal aberrations, namely, duplication or amplification of part of chromosome 5 containing the transgene and trisomy of chromosome 1, 6, or 12 in the genetic background of C3H x C57BL / 6 mouse and C3H x BALB / c mouse, respectively, regardless of cell type of lymphoma. These results suggest that non-random chromosomal abnormalities in lymphoma cells are dependent on the genetic background of mouse, not on the tumor cell type in Em-myc transgenic mouse.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376558      PMCID: PMC5926743          DOI: 10.1111/j.1349-7006.2001.tb01122.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  The Bloom's syndrome gene product is homologous to RecQ helicases.

Authors:  N A Ellis; J Groden; T Z Ye; J Straughen; D J Lennon; S Ciocci; M Proytcheva; J German
Journal:  Cell       Date:  1995-11-17       Impact factor: 41.582

3.  15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia.

Authors:  J D Rowley; H M Golomb; C Dougherty
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

4.  Positional cloning of the gene for Nijmegen breakage syndrome.

Authors:  S Matsuura; H Tauchi; A Nakamura; N Kondo; S Sakamoto; S Endo; D Smeets; B Solder; B H Belohradsky; V M Der Kaloustian; M Oshimura; M Isomura; Y Nakamura; K Komatsu
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

5.  Cytogenetic analysis of hepatic cell lines derived from SV40-T antigen gene-harboring transgenic mice.

Authors:  J Liu; H Li; K Nomura; R Dofuku; T Kitagawa
Journal:  Cancer Genet Cytogenet       Date:  1991-09

6.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Authors:  F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

7.  Location of the mouse complement factor H gene (cfh) by FISH analysis and replication R-banding.

Authors:  Y Matsuda; Y N Harada; S Natsuume-Sakai; K Lee; T Shiomi; V M Chapman
Journal:  Cytogenet Cell Genet       Date:  1992

Review 8.  Translocations among antibody genes in human cancer.

Authors:  P Leder; J Battey; G Lenoir; C Moulding; W Murphy; H Potter; T Stewart; R Taub
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

9.  Standard karyotype of the mouse, Mus musculus.

Authors: 
Journal:  J Hered       Date:  1972 Mar-Apr       Impact factor: 2.645

10.  Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.

Authors:  S Ohno; S Migita; F Wiener; M Babonits; G Klein; J F Mushinski; M Potter
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  1 in total

1.  Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice.

Authors:  Myung-Soo Kang; Hongxiang Lu; Teruhito Yasui; Arlene Sharpe; Henry Warren; Ellen Cahir-McFarland; Roderick Bronson; Siu Chun Hung; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.